Elizabeth Czerepak - Nov 18, 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Stock symbol
SRNEQ
Transactions as of
Nov 18, 2021
Transactions value $
$0
Form type
4
Date filed
11/18/2021, 04:11 PM
Previous filing
Nov 18, 2021
Next filing
May 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Option (right to buy) Award $0 +100K $0.00 100K Nov 18, 2021 Common Stock 100K $6.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the original number of shares subject to the option shall vest on December 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.